| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 716.31M | 67.31% |
| Operating expense | — | — |
| Net income | -522.64M | 1.44% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 2162.HK returned +9.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +51.2% |
| 1 year | +9.8% |
| 5 years | +57.6% |
| All-time high | $80.30 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 2162.HK would be worth today ›No. Keymed Biosciences Inc. has not paid a dividend in the past 12 months.
Keymed Biosciences Inc. is part of the Healthcare sector.
Keymed Biosciences Inc. has a market cap of 23.66B HKD, based on the latest quote.